Biogen ends trial of Alzheimer's drug

Thursday, March 21, 2019 - 10:00 in Health & Medicine

Biotechnology giant Biogen said it was ending its Phase 3 trial of an Alzheimer's disease drug because it was not likely to "meet their primary endpoint."

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net